Fortress Biotech, Inc. - Insider Non-Derivative Transactions at AVENUE THERAPEUTICS, INC. (ATXI) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 31, 2025, Fortress Biotech, Inc.'s relationship to AVENUE THERAPEUTICS, INC. (ATXI) is TenPercentOwner, and currently has 328,524 shares of COMMON STOCK, PAR VALUE $0.0001, and 1,032,390 shares of Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ATXI insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Fortress Biotech, Inc. - Insider Non-Derivative Transactions of ATXI COMMON STOCK, PAR VALUE $0.0001

Fortress Biotech, Inc. - Insider Non-Derivative Transactions of ATXI Common Stock

Fortress Biotech, Inc. - Insider Non-Derivative Transactions at ATXI

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Apr 1, 2025	Acquisition -- (COMMON STOCK, PAR VALUE $0.0001)	33724	0	328524
Apr 17, 2024	Acquisition -- (COMMON STOCK, PAR VALUE $0.0001)	413507	0	3547393
Jan 3, 2024	Acquisition -- (COMMON STOCK, PAR VALUE $0.0001)	2101496	0	3133886
Sep 9, 2023	P -- (Common Stock)	418410	0.72	1032390
Apr 1, 2023	Acquisition -- (COMMON STOCK, PAR VALUE $0.0001)	52419	0	613980
Jan 4, 2023	Acquisition -- (COMMON STOCK, PAR VALUE $0.0001)	231316	0	561561
Jan 1, 2023	Acquisition -- (COMMON STOCK, PAR VALUE $0.0001)	90909	0	330245